Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Physician's Weekly. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Physician's Weekly or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

HER2+ Horizons: Episode 2: Sequencing After Progression—What Comes Next?

9:59
 
Share
 

Manage episode 508253546 series 2964307
Content provided by Physician's Weekly. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Physician's Weekly or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode, Sara Tolaney, MD, of Dana-Farber Cancer Institute, discusses sequencing strategies after progression in HER2-positive metastatic breast cancer. She reviews current second-line standards, considerations for patients with brain metastases, and emerging therapies in the post–T-DXd setting.

Let us know what you thought of this week’s episode on Twitter: @physicianswkly

Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at [email protected]!

Thanks for listening!

  continue reading

212 episodes

Artwork
iconShare
 
Manage episode 508253546 series 2964307
Content provided by Physician's Weekly. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Physician's Weekly or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode, Sara Tolaney, MD, of Dana-Farber Cancer Institute, discusses sequencing strategies after progression in HER2-positive metastatic breast cancer. She reviews current second-line standards, considerations for patients with brain metastases, and emerging therapies in the post–T-DXd setting.

Let us know what you thought of this week’s episode on Twitter: @physicianswkly

Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at [email protected]!

Thanks for listening!

  continue reading

212 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play